Potential neuroprotection of protodioscin against cerebral ischemia-reperfusion injury in rats through intervening inflammation and apoptosis

The aim of the current research is to investigate the cerebral-protection of protodioscin on a transient cerebral ischemia-reperfusion (I/R) model and to explore its possible underlying mechanisms. The rats were preconditioned with protodioscin at the doses of 25 and 50 mg kg(-1) prior to surgery. Then the animals were subjected to right middle cerebral artery occlusion (MCAO) using an intraluminal method by inserting a thread (90 min surgery). After the blood flow was restored in 24 h via withdrawing the thread, some representative indicators for the cerebral injury were evaluated by various methods including. TTC-staining, TUNEL, immunohistochemistry, and Western blotting. As compared with the operated rats without drug intervening, treatment with protodioscin apparently lowered the death rate and improved motor coordination abilities through reducing the deficit scores and cerebral infarct volume. What's more, an apparent decrease in neuron apoptosis detected in hippocampus CM and cortex of the ipsilateral hemisphere might attribute to alleviate the increase in Caspase-3 and Bax/Bc1-2 ratio. Meanwhile, concentrations of several main pro-inflammatory cytokines (TNF-alpha, IL-1 beta and IL-6) in the serum were also significantly suppressed. Finally, the NF-kappa B and I kappa Ba protein expressions in the cytoplasm of right injured brain were remarkably up-regulated, while NF-kappa B in nucleus was down-regulated. Therefore, these observed findings demonstrated that protodioscin appeared to reveal potential neuroprotection against the I/R injury due to its anti-inflammatory and anti-apoptosis properties. This therapeutic effect was probably mediated by the inactivation of NF-kappa B signal pathways. (C) 2016 Published by Elsevier Inc.